LUCENTIS vs NUFYMCO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. LUCENTIS and NUFYMCO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LUCENTIS	NUFYMCO
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RANIBIZUMAB	RANIBIZUMAB-LEYK
Manufacturer	Genentech Inc	Formycon Ag
Dosage forms	Injectable	Injectable
Drug class	Vascular Endothelial Growth Factor Inhibitor	—
Boxed warning	None	None
Treats	Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion	Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion

lucentis nufymco

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

RANIBIZUMAB

RANIBIZUMAB-LEYK

Manufacturer

Genentech Inc

Formycon Ag

Dosage forms

Injectable

Drug class

Vascular Endothelial Growth Factor Inhibitor

—

Boxed warning

None

Treats

Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion

Frequently asked questions

What is the difference between Lucentis and Nufymco?

Lucentis contains Ranibizumab, while Nufymco contains Ranibizumab-Leyk — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.